Cybin, Inc.
(Aequitas NEO Exchange : CYBN)

( )
CYBN After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Pharmaceuticals Major
JNJJohnson & Johnson -1.49%176.120.7%$1154.91m
LLYEli Lilly & Co. -0.17%368.681.1%$1075.50m
MRKMerck & Co., Inc. -0.98%108.930.7%$992.38m
PFEPfizer Inc. -2.01%49.710.9%$934.38m
ABBVAbbVie, Inc. -0.11%163.761.9%$884.04m
BMYBristol-Myers Squibb Co. -0.98%79.911.1%$741.36m
AZNAstraZeneca Plc 0.21%68.561.0%$355.43m
HZNPHorizon Therapeutics Plc -1.66%96.855.4%$295.13m
GSKGSK Plc 7.85%37.920.3%$247.06m
IDXXIDEXX Laboratories, Inc. -1.64%415.393.9%$191.92m
NVSNovartis AG -0.25%90.730.2%$185.59m
CTLTCatalent, Inc. -5.00%48.231.9%$175.42m
ALNYAlnylam Pharmaceuticals, Inc. -2.90%219.648.0%$156.22m
NVONovo Nordisk A/S -1.03%125.770.1%$154.68m
SNYSanofi 8.06%48.550.2%$133.18m

Company Profile

Cybin, Inc. is an ethical biopharmaceutical company engaged in the development of therapeutics for patients to address a multitude of mental health issues. It is focused on progressing psychedelics to therapeutics by engineering proprietary drug discovery platforms, innovative drug delivery systems, novel formulation approaches, and treatment regimens for mental health disorders. The company was founded by Paul Glavine, Eric So, and John Kanakis on October 13, 2016 and is headquartered in Toronto, Canada.